Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
3CLPRO PROTEASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/036140
Kind Code:
A1
Abstract:
Provided are a 3CLpro protease inhibitor, a pharmaceutical composition containing the compound of formula (I), and a method for treating coronavirus by using the compound.

More Like This:
WO/2015/013630METAL AMIDES OF CYCLIC AMINES
JPH072851FIVE-MEMBERED HETEROCYCLIC COMPOUND, ITS PREPARATION AND PHARMACEUTICAL CONTAINING IT
WO/1997/003473BATTERY PACK HOUSING DEVICE AND BATTERY PACK
Inventors:
WANG JUNFEI (CN)
CHENG CANG (CN)
CHI BO (CN)
SUN DAQING (CN)
Application Number:
PCT/CN2022/117336
Publication Date:
March 16, 2023
Filing Date:
September 06, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD (CN)
International Classes:
C07D401/02; A61K31/472; A61P31/14; C07D401/12; C07D401/14; C07D403/02; C07D403/12; C07D403/14
Domestic Patent References:
WO2000034238A12000-06-15
Foreign References:
CN113072497A2021-07-06
CN101519372A2009-09-02
CN202111044417A2021-09-07
CN202111226591A2021-10-21
CN202111470155A2021-12-03
CN202111674718A2021-12-31
CN202211031927A2022-08-26
CN113072497A2021-07-06
Attorney, Agent or Firm:
MERITS IP LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: DISPLAY DEVICE

Next Patent: LASER COMPOSITE REPAIRING METHOD FOR OFFSHORE PLATFORM PILE LEG CAPABLE OF ELIMINATING CLADDING LAYE...